Literature DB >> 2837535

ADP-ribosylation of highly purified rat brain mitochondria.

A Masmoudi1, F Islam, P Mandel.   

Abstract

Highly purified synaptic and nonsynaptic mitochondria were prepared from rat brain, and their ADP-ribosyl transferase and NAD glycohydrolase activities were investigated. Data show that there is no significant difference in ADP-ribosyl transferase activity between these two types of subcellular preparations. However, NAD glycohydrolase activity appeared to be much higher in nonsynaptic mitochondria. The specific activity of both enzymes was investigated in the presence of the inhibitor nicotinamide or its analogue 3-aminobenzamide or other adenine nucleotides, such as ATP or ADP-ribose. The inhibitory effect of nicotinamide or 3-aminobenzamide on ADP-ribosyl transferase appears rather weak compared with their effect on NAD glycohydrolase activity. However, ADP-ribose and ATP appeared more effective in inhibiting ADP-ribosyl transferase. Our results provide evidence for the existence of ADP-ribosyl transferase activity in rat brain mitochondria. When NAD glycohydrolase was inhibited totally by nicotinamide, the transfer of ADP-ribose from NAD to mitochondrial proteins still occurred. The chain length determinations show that the linkage of ADP-ribose to mitochondrial proteins is oligomeric.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837535     DOI: 10.1111/j.1471-4159.1988.tb04854.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Regulation of mitochondrial poly(ADP-Ribose) polymerase activation by the β-adrenoceptor/cAMP/protein kinase A axis during oxidative stress.

Authors:  Attila Brunyanszki; Gabor Olah; Ciro Coletta; Bartosz Szczesny; Csaba Szabo
Journal:  Mol Pharmacol       Date:  2014-07-28       Impact factor: 4.436

2.  Identification of bovine liver mitochondrial NAD+ glycohydrolase as ADP-ribosyl cyclase.

Authors:  M Ziegler; D Jorcke; M Schweiger
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Enzymic, cysteine-specific ADP-ribosylation in bovine liver mitochondria.

Authors:  D Jorcke; M Ziegler; A Herrero-Yraola; M Schweiger
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 4.  Sex differences in mitochondrial (dys)function: Implications for neuroprotection.

Authors:  Tyler G Demarest; Margaret M McCarthy
Journal:  J Bioenerg Biomembr       Date:  2014-10-08       Impact factor: 2.945

Review 5.  Mitochondrial poly(ADP-ribose) polymerase: The Wizard of Oz at work.

Authors:  Attila Brunyanszki; Bartosz Szczesny; László Virág; Csaba Szabo
Journal:  Free Radic Biol Med       Date:  2016-03-08       Impact factor: 7.376

Review 6.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

7.  Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity.

Authors:  Marianna N Rossi; Mariarosaria Carbone; Cassandra Mostocotto; Carmine Mancone; Marco Tripodi; Rossella Maione; Paolo Amati
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

8.  Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore.

Authors:  Manish Verma; Nataly Shulga; John G Pastorino
Journal:  Biochim Biophys Acta       Date:  2012-10-05

Review 9.  Aiming for the target: Mitochondrial drug delivery in traumatic brain injury.

Authors:  Andrew M Lamade; Elizabeth M Kenny; Tamil S Anthonymuthu; Elif Soysal; Robert S B Clark; Valerian E Kagan; Hülya Bayır
Journal:  Neuropharmacology       Date:  2018-07-30       Impact factor: 5.250

10.  Parp and cell death or protection in rat primary astroglial cell cultures under LPS/IFNgamma induced proinflammatory conditions.

Authors:  V Spina-Purrello; D Patti; A M Giuffrida-Stella; V G Nicoletti
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.